# Filing Detail

Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001140361-25-042879
Filing Date
2025-11-20
Accepted
2025-11-20 17:17:10
Documents
25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-4 | ny20057110x1_s4.htm | S-4 | 3658210
2 | EXHIBIT 5.1 | ny20057110x1_ex5-1.htm | EX-5.1 | 8436
3 | EXHIBIT 23.2 | ny20057110x1_ex23-2.htm | EX-23.2 | 2074
4 | EXHIBIT 23.3 | ny20057110x1_ex23-3.htm | EX-23.3 | 1975
5 | EXHIBIT 99.2 | ny20057110x1_ex99-2.htm | EX-99.2 | 4208
6 | EXHIBIT 99.3 | ny20057110x1_ex99-3.htm | EX-99.3 | 2991
7 | FILING FEE TABLE | ny20057110x1_exfees.htm iXBRL | EX-FILING FEES | 29474
8 |  | logo_astriax1.jpg | GRAPHIC | 35335
9 |  | logo_astriax2.jpg | GRAPHIC | 30133
10 |  | logo_biocrystnewx1.jpg | GRAPHIC | 18731
11 |  | logo_evercore.jpg | GRAPHIC | 15894
12 |  | logo_evercoreaddress.jpg | GRAPHIC | 28962
13 |  | ny20057110x1_ex5-1img001.jpg | GRAPHIC | 6471
14 |  | ny20057110x1_ex5-1img002.jpg | GRAPHIC | 3829
15 |  | ny20057110x1_ex5-1img003.jpg | GRAPHIC | 1597
| Complete submission text file | 0001140361-25-042879.txt |  | 4027279

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
27 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20057110x1_exfees_htm.xml | XML | 6847

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-291678 | Film No.: 251503940
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)